Skip to content
  • Home
  • About
  • Contact
  • Services
  • Advertise with Us
US Pharma Marketing Logo

US Pharma Marketing

  • Industry Landscape
  • Your POV
  • Sponsored
  • Case Studies & Trends
  • Job & Career
  • Strategy & Execution
  • Digital Transformation
  • Regulatory Compliance
  • Leader Q&A

Author: Jayshree Gondane

Jayshree Gondane, BHMS student and healthcare enthusiast with a genuine interest in medical sciences, patient well-being, and the real-world workings of the healthcare system.
Commercial Effectiveness KPIs for AI-Enabled Sales Teams | AI pharma KPIs
Posted in
  • Digital Transformation
  • Strategy & Execution

Commercial Effectiveness KPIs for AI-Enabled Sales Teams | AI pharma KPIs

The United States pharmaceutical market is among the largest and most complex in the world. In … Commercial Effectiveness KPIs for AI-Enabled Sales Teams | AI pharma KPIsRead more

by Jayshree Gondane•January 23, 2026January 23, 2026•0
AI Tools to Predict Which HCPs Prefer Virtual vs In-Person Engagement
Posted in
  • Strategy & Execution

AI Tools to Predict Which HCPs Prefer Virtual vs In-Person Engagement

Physician engagement models in the United States have fundamentally shifted since the COVID-19 pandemic, but the … AI Tools to Predict Which HCPs Prefer Virtual vs In-Person EngagementRead more

by Jayshree Gondane•January 22, 2026January 22, 2026•0
Sales Acceleration Tactics for Orphan Drugs| orphan drug marketing
Posted in
  • Strategy & Execution

Sales Acceleration Tactics for Orphan Drugs| orphan drug marketing

Orphan drugs, designed to treat rare diseases affecting fewer than 200,000 patients in the United States, … Sales Acceleration Tactics for Orphan Drugs| orphan drug marketingRead more

by Jayshree Gondane•January 22, 2026January 22, 2026
Smart Messaging Frameworks for Chronic Disease Brands in the U.S. Pharmaceutical Market
Posted in
  • Digital Transformation
  • Regulatory Compliance

Smart Messaging Frameworks for Chronic Disease Brands in the U.S. Pharmaceutical Market

Chronic diseases represent a growing challenge in the United States, accounting for nearly 90% of annual … Smart Messaging Frameworks for Chronic Disease Brands in the U.S. Pharmaceutical MarketRead more

by Jayshree Gondane•January 22, 2026January 22, 2026•0
Using Machine Learning for KOL Strategy Optimization | KOL optimization AI
Posted in
  • Digital Transformation
  • Regulatory Compliance

Using Machine Learning for KOL Strategy Optimization | KOL optimization AI

In the U.S. pharmaceutical industry, influence no longer flows through clearly defined hierarchies of senior physicians … Using Machine Learning for KOL Strategy Optimization | KOL optimization AIRead more

by Jayshree Gondane•January 22, 2026January 22, 2026•0
Personalization Engines for Pharma Landing Pages in the U.S. Market
Posted in
  • Digital Transformation
  • Regulatory Compliance

Personalization Engines for Pharma Landing Pages in the U.S. Market

In 2024, U.S. physicians reported spending less than 1.5 minutes on average on branded pharmaceutical websites, according to … Personalization Engines for Pharma Landing Pages in the U.S. MarketRead more

by Jayshree Gondane•January 20, 2026January 20, 2026•0
AI Personas for Targeted Pharma Content AI personas pharma
Posted in
  • Digital Transformation
  • Regulatory Compliance

AI Personas for Targeted Pharma Content AI personas pharma

The pharmaceutical industry is undergoing a transformation driven by digital innovation, regulatory pressures, and the need … AI Personas for Targeted Pharma Content AI personas pharmaRead more

by Jayshree Gondane•January 18, 2026January 18, 2026•0
Automated Medical Education Funnels for Specialists in the U.S. Pharmaceutical Market
Posted in
  • Digital Transformation
  • Regulatory Compliance

Automated Medical Education Funnels for Specialists in the U.S. Pharmaceutical Market

The U.S. pharmaceutical market remains the largest and most complex in the world, with annual prescription … Automated Medical Education Funnels for Specialists in the U.S. Pharmaceutical MarketRead more

by Jayshree Gondane•January 18, 2026January 18, 2026•0
How Non-Traditional Data Sources Are Transforming HCP Discovery in Pharma
Posted in
  • Digital Transformation
  • Industry Landscape

How Non-Traditional Data Sources Are Transforming HCP Discovery in Pharma

The pharmaceutical industry has always relied on healthcare professional (HCP) discovery as the cornerstone of its … How Non-Traditional Data Sources Are Transforming HCP Discovery in PharmaRead more

by Jayshree Gondane•January 17, 2026January 17, 2026•0
Demand Mapping for New Biotech Entrants |Biotech Demand Mapping
Posted in
  • Digital Transformation
  • Industry Landscape
  • Strategy & Execution

Demand Mapping for New Biotech Entrants |Biotech Demand Mapping

Entering the U.S. biotech market is both a high-stakes opportunity and a complex challenge. Startups and … Demand Mapping for New Biotech Entrants |Biotech Demand MappingRead more

by Jayshree Gondane•January 17, 2026January 17, 2026•0

Posts pagination

Previous 1 … 12 13 14 … 20 Next

Recent Posts

  • The Silent Architects: How Private Equity Is Rewriting the Rules of Pharmaceutical Commercialization
  • Location Is the New Targeting: How Geofencing Is Changing Who Gets Diagnosed and Treated
  • When a Drug Loses Its Patent, Marketing Becomes Defense, Not Growth
  • The Hidden Compliance Risk of AI in Pharmaceutical Promotion
  • The Truth About Drug Price Transparency Laws and Pharmaceutical Marketing Strategy

Recent Comments

No comments to show.
Copyright © 2026 US Pharma Marketing.
Powered by WordPress and HybridMag.
  • Industry Landscape
  • Your POV
  • Sponsored
  • Case Studies & Trends
  • Job & Career
  • Strategy & Execution
  • Digital Transformation
  • Regulatory Compliance
  • Leader Q&A